Skip to main content
TipRanks
Go Ultimate75% OFF

Gongwin Biopharm Holdings Co., Ltd. (6617) Ownership - Who Owns Gongwin Biopharm Holdings Co., Ltd.?

Gongwin Biopharm Holdings Co., Ltd. (6617) Ownership Overview

  • 0.02% ETFs
  • 99.98% Public Companies and Individual Investors

The ownership structure of Gongwin Biopharm Holdings Co., Ltd. (TW:6617) stock is a mix of institutional, retail, and individual investors. Approximately 0.02% of the company’s stock is owned by Institutional Investors, and 99.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

TW:6617 top shareholders
Holder# of SharesType% HoldingValue
State Street22,875Institution0.02%69,792

Top ETF Holders

TW:6617 top ETF holders
Holder# of SharesType% HoldingValue
State Street, EWX ETF22,875Institution0.02%71,598

FAQ

What percentage of Gongwin Biopharm Holdings Co., Ltd. (TW:6617) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.02% of Gongwin Biopharm Holdings Co., Ltd. (TW:6617) stock is held by institutional investors.
What percentage of Gongwin Biopharm Holdings Co., Ltd. (TW:6617) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.98% of Gongwin Biopharm Holdings Co., Ltd. (TW:6617) stock is held by public companies and individual investors.
Who owns the most shares of Gongwin Biopharm Holdings Co., Ltd. (TW:6617)?
State Street owns the most shares of Gongwin Biopharm Holdings Co., Ltd. (TW:6617).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.